Player FM - Internet Radio Done Right
35 subscribers
Checked 2y ago
تمت الإضافة منذ قبل twelve عام
المحتوى المقدم من Cancer Network. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Cancer Network أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Player FM - تطبيق بودكاست
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
Supreme Court Decides on the Affordable Care Act
Manage episode 56713339 series 9908
المحتوى المقدم من Cancer Network. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Cancer Network أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
We speak with two practicing oncologists, Dr. Paul R. Helft and Dr. David Eagle, about how the recent Supreme Court decision to uphold the Affordable Care Act will affect oncology practices and cancer patients.
…
continue reading
56 حلقات
Manage episode 56713339 series 9908
المحتوى المقدم من Cancer Network. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة Cancer Network أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
We speak with two practicing oncologists, Dr. Paul R. Helft and Dr. David Eagle, about how the recent Supreme Court decision to uphold the Affordable Care Act will affect oncology practices and cancer patients.
…
continue reading
56 حلقات
Все серии
×![Artwork](/static/images/128pixel.png)
1 ONS: Infection Risk, Prevention, and Management 11:37
11:37
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب11:37![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
In this interview, Laura Zitella will be discussing challenges and considerations for management and prevention of infection in the oncology setting—in both patients with solid tumors and those with hematologic malignancies.
This interview covers standards for healthcare provider competency in offering comprehensive genetic services, and highlighting genetics/genomics resources for nurses.
In this interview, Tami Borneman, who is presenting a poster at the 38th Annual ONS Congress, will discuss spirituality: what it means, and how spiritual interventions can benefit patients with cancer.
This interview covers symptom management and quality-of-life outcomes in cancer clinical trials, which are being incorporated more readily as secondary and sometimes primary trial endpoints.
In this interview, ahead of the AACR annual meeting, we speak with Dr. Julie Brahmer, of Johns Hopkins School of Medicine, who is giving a presentation on immunotherapy in lung cancer, and is one of the clinical investigators of the extensive phase I trial of the anti–PD-1 antibody nivolumab.
This interview covers symptom management and quality-of-life outcomes in cancer clinical trials, which are being incorporated more readily as secondary and sometimes primary trial endpoints.
![Artwork](/static/images/128pixel.png)
1 Treatment Combinations for HER2-Postive Breast Cancer 12:28
12:28
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب12:28![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
As part of our coverage for the 30th Annual Miami Breast Cancer Conference, we bring you an interview with Dr. Mark Pegram, director of the breast cancer program at the Stanford Women’s Cancer Center and codirector of the molecular therapeutics program. Dr. Pegram will be discussing the potential for novel HER2 combination therapies at the conference.…
In this interview we discuss the dissemination of research results, clinical trials, and other oncology news using social media, as well as what type of media oncologists use, and how useful and relevant this type of information is for most oncologists.
![Artwork](/static/images/128pixel.png)
1 Status of HPV-Related Cancers and Vaccination Trends 13:56
13:56
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب13:56![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
In this interview we discuss HPV-associated cancers, which are on the rise, and the low vaccination coverage for HPV with Edgar Simard, PhD, MPH, senior epidemiologist of surveillance research, who studies the impact of prevention and screening on cancer incidence at the American Cancer Society.
Ahead of the ASCO GU meeting, we spoke with two symposium committee members, Dr. Mack Roach, of the University of California, San Francisco, and Dr. Hans T. Chung, of the University of Toronto, about early treatment and surveillance of prostate cancer patients.
![Artwork](/static/images/128pixel.png)
1 Novel Multiple Myeloma Treatments and Agents in Development 11:34
11:34
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب11:34![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
In this interview we discuss the current management and latest treatments and agents in development for multiple myeloma with Dr. Kenneth Anderson of the Dana-Farber Cancer Institute.
In this interview we discuss the latest treatments and research for gastrointestinal cancers with Dr. Cathy Eng, associate professor, department of gastrointestinal medical oncology, The University of Texas MD Anderson Cancer Center.
![Artwork](/static/images/128pixel.png)
1 Latest Treatment and Research for Chronic Myeloid Leukemia 15:36
15:36
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب15:36![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
In this interview we discuss the latest chronic myeloid leukemia treatment and research with Dr. Michael Deininger, chief of the division of hematology at the University of Utah School of Medicine.
![Artwork](/static/images/128pixel.png)
1 Patient Expectations About Their Cancer Treatment 10:11
10:11
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب10:11![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
In this interview we discuss what patients expect from their cancer treatment with Deborah Schrag, MD, MPH, associate professor at Harvard Medical School. Dr. Schrag recently published a study that aimed to discover how patients with advanced cancer understand the purpose of their chemotherapy treatment.…
![Artwork](/static/images/128pixel.png)
1 ASH: Repurposed Drugs Show Promise in Multiple Myeloma 5:52
5:52
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب5:52![icon](https://imagehost.player.fm/icons/general/red-pin.svg)
Today we speak with Steven T. Rosen, MD, about a couple of the projects he and his group are working on, repurposing old drugs for the treatment of multiple myeloma, that will be presented this year at ASH.
مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.